MedPath

Effectiveness of Botulinum Toxin Injection in the Tennis Elbow Treatment

Phase 3
Completed
Conditions
Tennis Elbow
Interventions
Drug: Placebo injection
Registration Number
NCT00437762
Lead Sponsor
University Hospital, Bordeaux
Brief Summary

Some studies valued the effectiveness of botulinum toxin. Results are contradictory and we need more studies. The purpose of the study is to compare the effectiveness of botulinum toxin injection with placebo in the treatment of tennis elbow unrelieved by usual medical care performed during 6 months. Method : It is a double blind randomized controlled trial. Principal criteria of assessment is Pain intensity three months after injection.

Detailed Description

* Principal Objective : The first aim of the study is to value the effectiveness of botulinum toxin injection in the treatment of tennis elbow unrelieved by usual medical care performed during 6 months..

* Secondary Objective : The second aim of this study is to document the tennis elbow history by a one year following after initial injection

* Study design : It is a double blind randomized controlled trial. Principal criteria of assessment is Pain intensity three months after injection.

* Inclusion criteria : tennis elbow during more than 6 months ; signature of consent

* Exclusion criteria : Non inclusion criteria : less than 18 years old ; osteoarthritis elbow, referred cervical pain, fibromyalgia, pregnancy, myasthenia, polymyositis, SLA, anticoagulant treatment, aminosides ; diabetes, alcoholism

* Study plan: randomized parallel groups

* Number of subjects : 60

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
61
Inclusion Criteria
  • Tennis elbow during more than 6 months
  • Signature of consent
Exclusion Criteria
  • Less than 18 years old
  • Osteoarthritis elbow
  • Referred cervical pain
  • Fibromyalgia
  • Pregnancy
  • Myasthenia
  • Polymyositis
  • SLA
  • Anticoagulant treatment
  • Aminosides
  • Diabetes
  • Alcoholism
  • Previous botulinum toxin A injections

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
1Botulinum Toxin A InjectionBotulinum Toxin A Injection
2Placebo injectionPlacebo injection
Primary Outcome Measures
NameTimeMethod
Principal criteria of assessment is pain intensity three months after injection.at 3 month
Secondary Outcome Measures
NameTimeMethod
Number of painful daysto day 30, 90,180, 365
Number of associated treatments.to day 30, 90,180, 365
Rate of recidivism after initial reliefto day 30, 90,180, 365
pain intensityto day 30, 90,180, 365
Free pain grip strengthto day 30, 90,180, 365

Trial Locations

Locations (1)

Unité de médecine orthopédique- Hôpital Pellegrin RDC aile 2.

🇫🇷

Bordeaux cedex, France

© Copyright 2025. All Rights Reserved by MedPath